Synthesis and electroluminescent property of novel europium complexes with oxadiazole substituted 1,10-phenanthroline and 2,2′-bipyridine ligands

Zhuqi Chen , Fei Ding , Feng Hao , Ming Guan , Zuqiang Bian *, Bei Ding and Chunhui Huang
Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, 100871, Beijing, China. E-mail: bianzq@pku.edu.cn; Fax: +86 10-6275-7156; Tel: +86 10-6275-7156

Received (in Montpellier, France) 7th September 2009 , Accepted 10th November 2009

First published on 13th January 2010


Abstract

Several 1,10-phenanthroline derivatives (PhoR), 2,2′-bipyridine derivatives (BpoR) and related europium complexes Eu(TTA)3PhoR and Eu(TTA)3BpoR were synthesized (HTTA = 2-thenoyltrifluoroacetone). Single crystal X-ray diffraction of Eu(TTA)3Php (Php = 2-(pyridyl)-1,10-phenanthroline) shows that Php acts as a tridentate NNN ligand, leading to a high stability of the complex for vacuum evaporation. When an oxadiazole moiety is incorporated into the ligand, the corresponding europium complexes show improved carrier-transporting abilities as well as thermal stabilities under vapor deposition for electroluminescence (EL) applications. Experiments revealed that these complexes have high photoluminescence (PL) quantum yields due to suitable triplet energy levels (ET) of the ligands, between 19[thin space (1/6-em)]724 and 22[thin space (1/6-em)]472 cm−1, for the sensitization of Eu(III) (5D0: 17[thin space (1/6-em)]500 cm−1). Utilizing Eu(TTA)3PhoB (PhoB = 2-(5-phenyl-1,3,4-oxadiazol-2-yl)-1,10-phenanthroline) as the dopant emitter in CBP (4,4′-N,N′-dicarbazolebiphenyl), EL devices with a structure of TPD (4,4′-bis[N-(p-tolyl)-N-phenylamino] biphenyl, 30 nm)/Eu(TTA)3PhoB:CBP (7.5%, 20nm)/BCP (2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline, 20 nm)/Alq3 (tris(8-hydroxyquinoline), 30 nm) exhibited a pure emission from europium ions. The highest efficiency obtained was 5.5 lm W−1, 8.7 cd A−1 and the maximum brightness achieved was 1086 cd m−2. At a practical brightness of 100 cd m−2, the efficiency remains above 2.0 cd A−1.


Introduction

For organic electroluminescence (EL) devices, the development of high-performance red emission is still much in demand. Rare earth complexes have been used as emitters in organic light-emitting diodes (OLEDs) due to their sharp-band emissions and high photoluminescence (PL) quantum yields.1–5 Many europium complexes have been investigated because they are known as excellent red phosphors that exhibit intense sharp red light at around 613 nm while other red organic emitting materials give broad emission spectra with bandwidths of around 100 nm resulting dull colors.6–14 However, OLEDs based on europium(III) complexes do not show satisfying brightness and efficiency due to their poor carrier transporting abilities.2,11 There are two methods of modification: one is introducing carrier transporting groups to ligands,15–20 the other is doping europium complexes into host materials with good semiconductor properties.11,21–25 Indeed, the EL efficiencies of europium complex-based OLEDs were enhanced through the above methods. However, the performances achieved are not satisfactory compared to organic molecules and polymer-based LEDs. Therefore, further improvement of OLEDs based on europium complexes is of great importance. When carrier transporting groups are introduced to the ligands, high molecular weights bring another key problem: volatilities and thermal stabilities of europium complexes during the vacuum evaporation.26,27 After all, while many advances have been made, europium complexes including high quantum efficiencies, good carrier transporting abilities and thermal abilities for deposition are still in demand. Based on these considerations, novel 1,10-phenanthroline and 2,2′-bipyridine derivatives and related europium complexes were designed and synthesized. By single crystal X-ray diffraction we confirm that 2-(pyridyl)-1,10-phenanthroline (Php) offers three coordination atoms which contribute to a high stability of the related complex.28,29 The pyridine moiety is further replaced by an oxadiazole moiety, which have been proven to be very effective in improving the injection and transport of electrons.30–32 By comparing element analysis data of the complex before and after sublimation, we figure that europium complexes with these oxadiazole substituted ligands maintain thermal stability for deposition. Furthermore, the triplet energy levels (ET) of the ligands are suitable for complete energy transfer to central ions, which leads to high quantum yields of related complexes. The utilization of these novel complexes as red emitters in EL devices are explored and remarkable performances are achieved.

Results and discussion

As shown in Scheme 1, Compounds 1, 2 and 3 were synthesized according to reported procedures.33,34 Reaction of compound 3 with a variety of benzoyl chloride derivatives afforded the neutral ligands. Then, based on the well-known formation of eight-coordinate adducts between {Ln(dik)3} units and N,N-bidentate chelates, europium complexes Eu(TTA)3Php, Eu(TTA)3PhoR and Eu(TTA)3BpoR were synthesized and characterized. Details were described in the experimental section.
Synthetic routes, chemical structures and corresponding abbreviations of the neutral ligands and europium complexes.
Scheme 1 Synthetic routes, chemical structures and corresponding abbreviations of the neutral ligands and europium complexes.

Crystal and molecular structure

Single crystals of Eu(TTA)3Php were isolated from acetone and ethanol solutions and analyzed by X-ray diffraction. The X-ray diffraction data were collected on a Rigaku MicroMax-007 CCD diffractometer by the ω scan technique at 131 K using graphite-monochromated Mo/Kα (λ = 0.71073 Å) radiation. An absorption correction by multiscan was applied to the intensity data. The structures were solved by the direct method, and the heavy atoms were located from the E-map. The remaining nonhydrogen atoms were determined from the successive difference Fourier syntheses. The non-hydrogen atoms were refined anisotropically, whereas the hydrogen atoms were generated geometrically with isotropic thermal parameters. The structures were refined on F2 by full-matrix least-squares methods using the SHELXTL-97 program package.

The europium ion was surrounded by six oxygen atoms from the bidentate β-diketonate ligands and three nitrogen atoms from the neutral ligand Php (Fig .1). The coordination polyhedron can be described as a distorted square antiprism. The lengths of Eu–N are 2.596(4), 2.650(4) and 2.603(4) Å. They are shorter than those in previous reports of NNN ligand based europium complexes (2.68, 2.70 and 2.72 Å) in the literature.35–37 Shorter bond lengths suggest higher stability, which is presumed by the rigid structure of the phenanthroline moiety.


An ORTEP view of the crystal structure of Eu(TTA)3Php with partial atomic labeling. Thermal ellipsoids are drawn at the 30% probability level.
Fig. 1 An ORTEP view of the crystal structure of Eu(TTA)3Php with partial atomic labeling. Thermal ellipsoids are drawn at the 30% probability level.

Thermal stability for deposition

The chemical weight of materials increasing upon the introduction of modification groups usually leads to difficulty in evaporation of the complexes in vacuum. Previous reports showed that the neutral ligand phenanthroline was slightly dissociated in vapor deposition and the residue in the crucible became dark.26,27 We compare the element analysis data of both the products of europium complexes from sublimation and residues left in the crucible. For Eu(TTA)3Phen, an obvious decrease of C, H, and N contents of the product after sublimation is observed (Table 1). The products were presumed to be a mixture of Eu(TTA)3Phen and Eu(TTA)3. The neutral ligand dissociates in the sublimation process. Meanwhile, Eu(TTA)3PhoR remains as a white powder after vacuum evaporation for many times. Taking Eu(TTA)3PhoB as an example, we compared the elemental analysis data of both the product from vacuum evaporation and the residue. They were both coincident with calculated values. The melting points (Tm) and the thermal decomposition temperatures (Td) of the complexes are also measured and are listed in Table 2. No glass transition temperature or crystallization temperature is found in any of these complexes. Thus, with the substituted 1,3,4-oxadiazole group, Eu(TTA)3PhoR shows the desired thermal stability for deposition. This stability makes devices fabricated by vacuum evaporation more feasible.
Table 1 Element analysis data of europium complexes
Complexes Products from sublimation Residue left in crucible Calculated valuesa
a According to the molecular formula.
Eu(TTA)3PhoB C: 46.43 C: 46.05 C: 46.36
(C44H24EuF9N4O7S3) H: 2.27 H: 2.10 H: 2.12
  N: 4.80 N: 4.92 N: 4.92
Eu(TTA)3Phen C: 40.23 C: 50.12 C: 44.49
(C36H20EuF9N2O6S3) H: 1.83 H: 3.26 H: 2.55
  N: 2.43 N: 1.39 N: 2.73
Eu(TTA)3     C: 35.35
(C24H12EuF9O6S3)     H: 1.48
      N: —


Table 2 Thermal stabilities and photophysical data of Eu complexes
Complexes T d/°C T m/°C λ max(abs)/nm (ε/dm3 mol−1 cm−1)
Eu(TTA)3Php 290.5 242 303 (35[thin space (1/6-em)]971)
341 (33[thin space (1/6-em)]854)
Eu(TTA)3PhoA 282.8 239 304 (43[thin space (1/6-em)]040)
343 (45[thin space (1/6-em)]710)
Eu(TTA)3PhoB 327.2 261 269 (31[thin space (1/6-em)]820)
308 (45[thin space (1/6-em)]520)
343 (55[thin space (1/6-em)]030)
Eu(TTA)3PhoC 307.9 262 266 (30[thin space (1/6-em)]260)
345 (46[thin space (1/6-em)]480)
Eu(TTA)3BpoA 281.4 224 271 (42[thin space (1/6-em)]210)
345 (40[thin space (1/6-em)]610)
Eu(TTA)3BpoB 285.6 227 274 (53[thin space (1/6-em)]760)
343 (46[thin space (1/6-em)]980)
Eu(TTA)3BpoC 293.9 231 275 (40[thin space (1/6-em)]910)
345 (52[thin space (1/6-em)]980)


Photophysical studies

For further research on EL properties of corresponding europium complexes, their photophysical properties were investigated. We focused more on the oxadiazole substituted ligands (PhoR and BpoR) rather than on Php, which had been reported before.34,38 The absorption spectra of europium complexes in CH2Cl2 (10−5 mol L−1) at room temperature are shown in Fig. 2. Similar absorption bands of Eu(TTA)3PhoR were observed at about 264 nm and 305 nm, while those of Eu(TTA)3BpoR were observed at 275 nm and 322 nm. These broad absorption bands are due to both TTA and neutral ligands.14 All of the complexes show the same lowest absorption maximums at about 340 nm and their low energy absorption edges at 390–400 nm. This distinct absorption band is probably assigned to the π → π* transition of the anionic ligand TTA.39
Absorption spectra of europium complexes in CH2Cl2 (10−5 mol L−1).
Fig. 2 Absorption spectra of europium complexes in CH2Cl2 (10−5 mol L−1).

The PL spectra of the complexes show characteristic europium ion emissions at λ = 579 nm (5D07F0), 588–597 nm (5D07F1), 613–620 nm (5D07F2), 650 nm (5D07F3) and 692 nm (5D07F4) (Fig. 3). Since the 7F0 state of Eu3+ is nondegenerate, the 5D07F0 transition can not be split by the ligand field. Therefore, the single peak at 579 nm in the emission spectrum indicates that there is only one luminescent Eu3+ species in solution.40 The splitting of the 5D07F1 and 5D07F2 transition, caused by the ligand field, is about 200 cm−1 and the intensity ratio of 5D07F2 transition and 5D07F1 transition (I7F2/I7F1) is about 19. Since the distortion of the symmetry around the central ion causes an intensity enhancement of the hypersensitive 5D07F2 transition and the intensity of the 5D07F1 transition is independent of the coordination sphere, the high I7F2/I7F1 indicates that the symmetry of the coordination sphere is low.41


PL spectra of europium complexes in CH2Cl2 (10−5 mol L−1).
Fig. 3 PL spectra of europium complexes in CH2Cl2 (10−5 mol L−1).

It is known that the sensitization pathway in lanthanide complexes generally consists of excitation of the ligand into its singlet excited state, subsequent intersystem crossing to its triplet state and energy transfer from the triplet state of the ligand to the lanthanide ion.40,42,43 The singlet energy levels (ES) and triplet energy levels (ET) of the ligands and the PL quantum yields (Φ) of the related complexes were measured (Fig. 4) and are listed in Table 3. The singlet energy levels were determined by fluorescence spectra of the ligands (10−5 mol L−1 in CH2Cl2, room temperature). The phosphorescence spectra of the related gadolinium complexes (10−5 mol L−1 in ethanol, 78 K) reveal the lowest triplet energy levels of the ligands because the lowest excited state 6P7/2 energy of Gd(III) is too high to accept energy from the ligands. PhoA with three fluoro substituents as an electron drawing group shows higher ET (20[thin space (1/6-em)]492 cm−1) than that of PhoB (19[thin space (1/6-em)]841 cm−1) while PhoC with tert-butyl as an electron pushing group shows lower ET (19[thin space (1/6-em)]724 cm−1). All of three ligands show a lower ET than phenanthroline (21[thin space (1/6-em)]480 cm−1),41 as the π-system of the ligand is extended by the oxadiazole group. Moreover, the fluorescence peaks of PhoA and PhoC show hypsochromic and bathochromic shifts compared with that of PhoB, respectively. This confirms that the addition of the electron-pushing tert-butyl group or the electron-withdrawing fluorine substituents on the phenyl ring alters the electronic density of the π-system; therefore, they reduce or increase both the singlet and the triplet energy level of the ligand. A similar phenomenon is observed in bipyridine derivatives and all of them show a lower ET than that of bipyridine (22[thin space (1/6-em)]900 cm−1).44 As all of these complexes have similar coordination environments, the suitability of the energy gap between the triplet energy level of the ligand and the main luminescent energy level of the central ion (5D0 for Eu3+: 17[thin space (1/6-em)]500 cm−1) is therefore critical for the efficiency of the energy transfer. By comparing the energy gaps and the quantum yields (Table 3), a general tendency is observed that a smaller energy gap (ET5D0) leads to a higher quantum yield of the related complex.


Fluorescence spectra of the ligands (a, b) in CH2Cl2 (10−5 mol L−1) and phosphorescence spectra of the related gadolinium complexes in ethanol (10−5 mol L−1) at 78 K (c, d).
Fig. 4 Fluorescence spectra of the ligands (a, b) in CH2Cl2 (10−5 mol L−1) and phosphorescence spectra of the related gadolinium complexes in ethanol (10−5 mol L−1) at 78 K (c, d).
Table 3 Singlet and triplet state energy levels of the ligands and quantum yields (Φ) of related europium complexes
Ligand ES/cm−1 ET/cm−1 ET5D0/cm−1 Φa
a Measured in CH2Cl2 by using Ru(bpy)3Cl2 distilled water as a reference compound (ref. 44).
PhoA 28[thin space (1/6-em)]329 20[thin space (1/6-em)]492 2992 30%
PhoB 28[thin space (1/6-em)]169 19[thin space (1/6-em)]841 2341 40%
PhoC 26[thin space (1/6-em)]525 19[thin space (1/6-em)]724 2224 42%
BpoA 29[thin space (1/6-em)]070 22[thin space (1/6-em)]472 4972 16%
BpoB 28[thin space (1/6-em)]902 22[thin space (1/6-em)]075 4574 22%
BpoC 28[thin space (1/6-em)]409 21[thin space (1/6-em)]882 4382 26%


Electroluminescent properties

By introducing TPD and Alq3 as hole and electron transporting materials, respectively, and BCP as a hole blocking material, EL device A1 was fabricated. Eu(TTA)3(PhoB) was chose as the emitter for its high PL quantum yield as well as its good thermal stability. The structures and the performances of devices are listed in Table 4. Compared with previous reports of non-doped OLEDs based on Eu(TTA)3Phen,11,46 a higher brightness of 32 cd m−2 (160 mA cm−2) is achieved at a lower applied voltage (14 V). The EL spectra at high voltages show broad peaks at 660 nm (Fig. 5). Device A2 was fabricated with a CBP film complementing as a hole-transporting layer (HTL). Compared to device A1, the intensity of the broad peak at high wavelength decreases but an emission centered at 420 nm arises at high voltages in device A2. Thus, we presume that the broad peak at 660 nm is attributable to an exciplex of Eu(TTA)3PhoB and TPD. Moreover, it also demonstrates that the substituted 1,3,4-oxadiazole group is favorable to increase the electron-transporting ability of the complex, thus the carriers are mainly recombined between EML and HTL in these devices.
EL spectra of device A1 (a) and A2 (b) at different voltages.
Fig. 5 EL spectra of device A1 (a) and A2 (b) at different voltages.
Table 4 Performances of Eu complexes based OLEDsa
Device Device structure Turn-on voltage/V L [cd m2, V] η c [cd A−1, V] η p [lm W−1, V] CIE, 10 cd m−2(x, y)
a The data for brightness (L), current efficiency (ηc), and power efficiency (ηp) are the maximum values of devices.
A1 TPD (30 nm)/Eu(TTA)3PhoB (30 nm)/ BCP (5 nm)/Alq3 (30 nm) 9 32, 14 0.05,10 0.017,10 0.65, 0.35
A2 TPD (30 nm)/CBP (5 nm)/Eu(TTA)3PhoB (30 nm)/BCP (5 nm)/Alq3 (30 nm) 6 67, 14 0.53, 7 0.24,7 0.65, 0.33
B1 NPB (25 nm)/Eu(TTA)3PhoB:CBP (3%, 25 nm)/BCP (15 nm)/Alq3 (35 nm) 9 703, 18 3.0, 10 0.90,10 0.65, 0.32
B2 NPB (25 nm)/Eu(TTA)3PhoC:CBP (3%, 25 nm)/BCP (15 nm)/Alq3 (40 nm) 9 421, 20 2.56, 9 0.89, 9 0.63. 0.31
B3 NPB (25 nm)/Eu(TTA)3BpoB:CBP (3%, 25 nm)/BCP (15 nm)/Alq3 (30 nm) 10 424, 53 1.37,17 0.26,17 0.63. 0.31
C1 TPD (30 nm)/Eu(TTA)3PhoB:CBP (2.2%, 20 nm)/BCP(20 nm)/Alq3 (30 nm) 6 1099, 20 2.6, 10 0.8, 10 0.65, 0.32
C2 TPD (30 nm)/Eu(TTA)3PhoB:CBP (4.2%, 20 nm)/BCP (20 nm)/Alq3 (30 nm) 5 877, 19 8.7, 6 3.9, 6 0.64, 0.32
C3 TPD (30 nm)/Eu(TTA)3PhoB:CBP (7.5%, 20 nm)/BCP (20 nm)/Alq3 (30 nm) 4 1086, 17 8.7, 5 5.5, 5 0.65, 0.32


To avoid the exciplex at high voltages, NPB was used instead of TPD as a hole transporting material. Three devices B1–B3 with Eu(TTA)3PhoB, Eu(TTA)3PhoC, and Eu(TTA)3BpoB as dopant emitters in CBP (3%) were fabricated, respectively. All of the EL spectra of these devices show a strong emission of europium ions at 612 nm while an emission centered at 420 nm is observed at high voltages, similar to the spectrum of device A2. This additional purple-blue emission can be attributed to the direct emission from CBP.11 In device B1 a maximum brightness of 703 cd m−2 at 18 V, a current efficiency of 3.0 cd A−1 and a power efficiency of 0.90 lm W−1 at 10 V are achieved. In device B2 and B3, Eu(TTA)3PhoC and Eu(TTA)3BpoB are used instead of Eu(TTA)3PhoB, respectively. Device B2 shows a similar performance with a maximum brightness of 421 cd m−2 at 20 V, a current efficiency of 2.56 cd A−1 and a power efficiency of 0.89 lm W−1 at 9 V. However, the current efficiency and the power efficiency of device B3 is 1.37 cd A−1 and 0.26 lm W−1. This performance is consistent with their different PL quantum yields (Table 3). Strong roll-off characteristics of efficiencies at high voltages are observed in all devices (Fig. 7). The phenomenon is thought to be a result of some processes quenching the excited states.10,11,47

Using Eu(TTA)3PhoB as the guest emitter with concentrations from 2.2% to 7.5% in CBP, devices C1–C3 are fabricated. The structure was ITO/TPD (30 nm)/Eu(TTA)3PhoB:CBP (X%, 20 nm)/BCP (20 nm)/AlQ (30 nm)/Mg0.9Ag0.1. EL spectra of device C1 and C2 show a characteristic red emission of Eu(TTA)3PhoB with a weak emission at 420 nm (Fig. 6). All of the devices have maximum brightness around 1000 cd m−2. As the concentration of Eu(TTA)3PhoB is increased from 2.2% (device C1) to 7.5% (device C3), more excitons are contributed to the lanthanide luminescence process. A higher PL quantum yield of the lanthanide complexes (100% theoretical quantum efficiency) leads to higher EL efficiencies. Hence, the power efficiency and the current efficiency increase from 0.8 lm W−1 and 2.6 cd A−1 (device C1) to 5.5 lm W−1 and 8.7 cd A−1 (device C3) (Table 4). Device C3 shows a purer emission that originates from the europium complex. Even at the highest applied voltage, only a trace emission at 450 nm is observed (Fig. 8). This reveals that carriers are well confined within the emitting layer and the energy transfer between CBP and Eu(TTA)3PhoB is complete in this device. Thus, a remarkable performance of device C3 is achieved.


EL spectra of device B1, C1 and C2 at similar current densities.
Fig. 6 EL spectra of device B1, C1 and C2 at similar current densities.

EL performance of device C1–C3: brightness (a), current density (b), power efficiency (c) and current efficiency (d) versus voltage.
Fig. 7 EL performance of device C1–C3: brightness (a), current density (b), power efficiency (c) and current efficiency (d) versus voltage.

EL spectra of device C3 at different applied voltages.
Fig. 8 EL spectra of device C3 at different applied voltages.

Experimental

Methods and instruments

Alq3 was synthesized according to literature procedures48 and sublimed twice prior to use. CBP, NPB, TPD and BCP were purchased from Aldrich and used after sublimation. Eu(TTA)3Phen and Eu(TTA)3(H2O)2 were synthesized according to a previous report.49 Chromatographic separation was carried out on silica gel (200–300 mesh) for purification. The 1H NMR spectra were recorded on a Varian 400 MHz instrument using Me4Si as an internal reference. Mass spectra were recorded on a ZAB-HS and BIFLEX III. Elemental analyses were performed on a VARIO EL analyzer. Thermogravimetric and differential thermal analysis were carried out on Q600SDT and Q100DSC instruments at an elevation temperature rate of 10 °C min−1 under 100 mL min−1 nitrogen flow. EL and PL spectra were recorded with an Edinburgh Analytical Instruments FLS920 spectrometer after removing oxygen in the solution by a vacuum technique (3 or 4 freeze–pump–thaw cycles). Absorption spectra were measured on a Shimadzu UV-3100 UV-vis spectrometer. Solvents for reactions were distilled prior to use. Solvents used in photophysical experiments were of spectroscopic grade.

General procedure for the synthesis of the neutral ligands

2-(pyridyl)-1,10-phenanthroline, 1,10-phenanthroline 1-oxide (1) and 2-cyano-1,10-phenanthroline (2) were synthesized according to reported procedures.33,34 Compound 2 (4.1 g, 20 mmol), sodium azide (2.93 g, 45 mmol) and ammonium chloride (2.4 g, 45 mmol) in 30 ml of DMF was heated at 100 °C for 24 h. After cooling to room temperature the mixture was poured into 400 ml of water and acidified with dilute HCl. The resulting white precipitate was collected, washed with water, and dried in vacuum at 60 °C, yielding 2-(1H-tetrazol-5-yl)-1,10-phenanthroline (3).50 The benzoyl chloride derivative (22 mmol) was then added to a solution of 3 (4.96 g, 20 mmol) in 25 ml of pyridine, and the mixture was refluxed for 2 h under nitrogen flow. 200 mL of water was added to the cooled reaction mixture affording a white precipitate. The precipitate was isolated, washed with water and dried in vacuum at 60 °C. The 5-(1H-tetrazol-5-yl)-2,2′-bipyridine was synthesized with the same procedure of 3. Bipyridine derivatives were then synthesized with the same benzoyl chloride derivatives. The individual yields and important spectral data of these products are listed below.
2-(1H-tetrazol-5-yl)-1,10-phenanthroline (3). Yield: 72%. 1H NMR (400 MHz, DMSO-d6), 9.44–9.42 (q, 1H), 9.28–9.26 (d, 1H), 8.92–8.90 (d, 1H), 8.65–8.63 (d, 1H), 8.38–8.33 (m, 3H), MS (m/z): calcd. for C13H8N6 248, found 248.
5-(1H-tetrazol-5-yl)-2,2′-bipyridine. Yield: 78%. 1H NMR (400 MHz, DMSO-d6), 8.84–8.82 (d, 1H), 8.75–8.74 (d, 1H), 8.60–8.57 (d, 1H), 8.28–8.20 (m, 2H), 8.09–8.05 (t, 1H),7.55–7.54 (t, 1H), MS (m/z): calcd. for C11H8N6 224, found 224.
2-(5-(2,3,4-trifluorophenyl)-1,3,4-oxadiazol-2-yl)-1,10-phenanthroline (PhoA). Yield: 60%. 1H NMR (400 MHz, CDCl3), 9.31–9.29 (q, 1H), 8.70–8.6 7(d, 1H), 8.51–8.49 (d, 1H), 8.37–8.34 (q, 1H), 8.19–8.13 (m, 1H), 7.97–7.91 (q, 2H), 7.77–7.74 (q, 1H), 7.26–7.18 (m, 1H), MS (m/z): calcd. for C20H9F3N4O 378, found 378. Anal. calcd. for C20H9F3N4O: C, 63.50; H, 2.40; N, 14.81. Found: C, 63.50; H, 2.49; N, 14.88.
2-(5-phenyl-1,3,4-oxadiazol-2-yl)-1,10-phenanthroline (PhoB). Yield: 80%. 1H NMR (400 MHz, CDCl3), 9.23–9.22 (q, 1H), 8.79–8.77 (d, 1H), 8.62–8.60 (d, 1H), 8.58–8.56 (q, 1H), 8.23–8.20 (q, 2H), 8.16–8.11 (q, 2H), 7.88–7.85 (d, 1H), 7.72–7.69 (m, 3H), MS (m/z): calcd. for C20H12N4O 324, found 324. Anal. calcd. for C20H12N4O: C, 74.06; H, 3.73; N, 17.27. Found: C, 74.09; H, 3.76; N, 17.04. 13C NMR (400 MHz, CDCl3), 165.99 (C), 164.22 (C), 150.62 (CH), 145.86 (C), 145.55 (C), 143.25 (C), 137.33 (C), 136.29 (C), 131.92 (CH), 129.48 (C), 129.03 (CH), 128.82 (CH), 128.37 (CH), 127.56 (CH), 126.06 (CH), 123.50 (CH), 123.44 (CH), 122.13 (CH).
2-(5-(4-tert-butylphenyl)-1,3,4-oxadiazol-2-yl)-1,10-phenanthroline (PhoC). Yield: 60%. 1H NMR (400 MHz, CDCl3), 9.30–9.29 (q, 1H), 8.70–8.67 (d, 1H), 8.47–8.45 (d, 1H), 8.34–8.29 (m, 3H), 7.94–7.88 (q, 2H), 7.94–7.88 (q, 2H), 7.74–7.71 (q, 1H), 7.58–7.56 (m, 2H), 1.39 (s, 9H), MS (m/z): calcd. for C24H20N4O 380, found 380. Anal. calcd. for C24H20N4O: C, 75.77; H, 5.30; N, 14.73. Found: C, 75.66; H, 5.26; N, 14.72. 13C NMR (400 MHz, CDCl3), 166.02 (C), 163.98 (C), 155.44 (C), 150.59 (CH), 145.83 (C), 145.58 (C), 143.30 (C), 137.20 (C), 136.07 (C), 129.32 (C), 128.91 (CH), 128.23 (CH), 127.72 (CH), 125.92 (CH), 125.70 (CH), 123.36 (CH), 122.03 (CH), 120.54 (CH), 34.91 (C), 30.92 (CH3).
5-(5-(2,3,4-trifluorophenyl)-1,3,4-oxadiazol-2-yl)-2,2′-bipyridine (BpoA). Yield: 57%. 1H NMR (400 MHz, CDCl3), 8.73–8.71 (d, 1H), 8.66–8.61 (q, 2H), 8.32–8.30 (d, 1H), 8.06–8.00 (m, 2H), 8.00–7.8 8(t, 1H), 7.40–7.37 (t, 1H), 7.22–7.18 (m, 1H). MS (m/z): calcd. for C18H9F3N4O 354, found 354. Anal. calcd. for C18H9F3N4O: C, 61.02; H, 2.56; N, 15.81. Found: C, 61.09; H, 2.58; N, 15.77.
5-(5-phenyl-1,3,4-oxadiazol-2-yl)-2,2′-bipyridine (BpoB). Yield: 75%. 1H NMR (400 MHz, CDCl3), 8.74–8.73 (d, 1H), 8.67–8.63 (t, 2H), 8.33–8.31 (d, 1H), 8.26–8.24 (m, 2H), 8.06–7.02 (t, 1H), 7.95–7.91 (t, 1H), 7.62–7.55 (m, 3H), 7.42–7.39 (t, 1H). MS (m/z): calcd. for C18H12N4O 300, found 300. Anal. calcd. for C18H12N4O: C, 71.99; H, 4.03; N, 18.66. Found: C, 71.86; H, 4.08; N, 18.28. 13C NMR (400 MHz, CDCl3), 165.30 (C), 163.85 (C), 156.52 (C), 154.84 (C), 149.10 (CH), 142.85 (C), 137.92 (C), 136.92 (CH), 131.83 (CH), 128.94 (CH), 127.11 (CH), 124.21 (CH), 123.64 (CH), 122.90 (CH), 122.88 (CH), 121.41 (CH).
5-(5-(4-tert-butylphenyl)-1,3,4-oxadiazol-2-yl)-2,2′-bipyridine (BpoC). Yield: 81%. 1H NMR (400 MHz, CDCl3), 8.73–8.71 (d, 1H), 8.66–8.60 (q, 2H), 8.31–8.29 (d, 1H), 8.18–8.15 (d, 2H), 8.04–8.01 (t, 1H), 7.93–7.88 (t, 1H), 7.59–7.57 (d, 2H), 7.40–7.37 (t, 1H), 1.39 (s, 9H), MS (m/z): calcd. for C22H20N4O 356, found 356. Anal. calcd. for C22H20N4O: C, 74.14; H, 5.66; N, 15.72. Found: C, 74.09; H, 5.63; N, 15.67. Anal. calcd. for C18H12N4O: C, 71.99; H, 4.03; N, 18.66. Found: C, 71.86; H, 4.08; N, 18.28. 13C NMR (400 MHz, CDCl3), 165.37 (C), 163.64 (C), 156.45 (C), 155.41 (C), 154.86 (C), 149.06 (CH), 142.93 (C), 137.86 (C), 136.87 (CH), 126.94 (CH), 125.90 (CH), 124.15 (CH), 122.82 (CH), 122.74 (CH), 121.37 (CH), 120.81 (CH), 34.69 (C), 30.97 (CH3).

General procedure for the synthesis of europium complexes51

To a 100 ml side-arm flask under nitrogen, 2-thenoyltrifluoroancetone (0.916 g, 3 mmol), 2,2′-bipyridine or 1,10-phenanthroline (1 mmol) derivative (BpoR or PhoR), sodium hydroxide (0.12 g, 3 mmol) and 30 ml ethanol were added. The mixture was stirred at 60 °C, while 10 ml ethanol solution of EuCl3·6H2O (0.366 g, 1.00 mol) was added dropwise. The reaction mixture was heated and stirred at 60 °C for 2 h, and was then cooled to room temperature. The resulting precipitate was filtered off, then washed with water and cool ethanol in turn. The crude product was purified by recrystallization from ethanol solution. The yields and element analysis data of these products are presented below.
Eu(TTA)3(Php). Yield: 83%, Anal. calcd. for C41H23EuF9N3O6S3: C, 45.90; H, 2.16; N, 3.92. Found: C, 45.79; H, 2.13; N, 3.93.
Eu(TTA)3(PhoA). Yield: 83%, Anal. calcd. for C44H21EuF9N4O7S3: C, 44.27; H, 1.77; N, 4.69. Found: C, 44.19; H, 1.78; N, 4.78.
Eu(TTA)3(PhoB). Yield: 76%, Anal. calcd. for C44H24EuF9N4O7S3: C, 46.36; H, 2.12; N, 4.92. Found: C, 46.44; H, 2.09; N, 4.97.
Eu(TTA)3(PhoC). Yield: 83%, Anal. calcd. for C48H32EuF9N4O7S3: C, 48.21; H, 2.70; N, 4.68. Found: C, 48.15; H, 2.74; N, 4.75.
Eu(TTA)3(BpoA). Yield: 85%, Anal. calcd. for C42H21EuF9N4O7S3: C, 43.12; H, 1.81; N, 4.79. Found: C, 43.05; H, 1.85; N, 4.84.
Eu(TTA)3(BpoB). Yield: 79%, Anal. calcd. for C42H24EuF9N4O7S3: C, 45.21; H, 2.17; N, 5.02. Found: C, 45.13; H, 2.18; N, 4.97.
Eu(TTA)3(BpoC). Yield: 80%, Anal. calcd. for C46H32EuF9N4O7S3: C, 47.14; H, 2.75; N, 4.78. Found: C, 47.02; H, 2.80; N, 4.88.

General procedure for the synthesis of gadolinium complexes

2,2′-Bipyridine or 1,10-phenanthroline (1 mmol) derivative (PhoR or BpoR) and GdCl3·6H2O (0.370 g, 1.00 mol) were heated and stirred at 60 °C for 2 h, and then cooled to room temperature. The product was purified by recrystallization from an ethanol–water mixed solution. The element analysis data of these products are presented below.
GdCl3(PhoA). Anal. calcd. for C20H9Cl3F3GdN4O: C, 37.42; H, 1.41; N, 8.73. Found: C, 37.69; H, 1.48; N, 8.61.
GdCl3(PhoB). Anal. calcd. for C20H12Cl3GdN4O: C, 40.86; H, 2.06; N, 9.53. Found: C, 40.97; H, 2.15; N, 9.40.
GdCl3(PhoC). Anal. calcd. for C24H20Cl3GdN4O: C, 44.76; H, 3.13; N, 8.70. Found: C, 44.85; H, 3.20; N, 8.63.
GdCl3(BpoA). Anal. calcd. for C18H9Cl3F3GdN4O: C, 34.99; H, 1.47; N, 9.07. Found: C, 35.12; H, 1.55; N, 8.94.
GdCl3(BpoB). Anal. calcd. for C18H12Cl3GdN4O: C, 38.34; H, 2.14; N, 9.94. Found: C, 38.39; H, 2.19; N, 9.89.
GdCl3(BpoC). Anal. calcd. for C22H20Cl3GdN4O: C, 42.62; H, 3.25; N, 9.04. Found: C, 42.70; H, 3.29; N, 8.98.

OLED fabrication and measurement

EL devices were fabricated by sequentially depositing organic layers using thermal evaporation in one run under high vacuum (<8 × 10−5 Pa) onto a cleaned indium tin oxide (ITO) glass substrate with a sheet resistance of 7 Ω sq−1. The active device area was 3 × 3 mm. The cathode was made of a 200 nm thick layer of Mg0.9Ag0.1 alloy with an 80 nm thick Ag cap. The thickness of the deposited layer and the evaporation speed of the individual materials were monitored with quartz crystal monitors. Deposition rates were maintained at 0.05–0.2 nm s−1 for organic materials and 0.2–0.3 nm s−1 for the Mg0.9Ag0.1 alloy. All electrical testing and optical measurements were performed under ambient conditions. The EL spectra were measured with a Spectra Scan PR650. The current–voltage (IV) and luminance–voltage (LV) characteristics were measured with a computer controlled Keithley 2400 Sourcemeter unit with a calibrated silicon diode.

Conclusions

In summary, we report the design, synthesis, and EL application of several europium complexes with phenanthroline derivatives or bipyridine derivatives as neutral ligands. Our results suggest that using tridentate neutral ligand is a viable strategy for improving the stability of lanthanide complex for deposition. By incorporating an oxadiazole moiety into the ligand with further modifying, we achieved novel complexes with characteristic emissions and high quantum yields, improved carrier transporting abilities and thermal stabilities for vapor deposition. These in turn lead to pure EL emissions and high efficiencies in appropriately configured devices. The modification of proper tridentate ligands with functional groups provides a useful guide for future work on lanthanide based OLEDs.

Acknowledgements

The authors thank the National Basic Research Program (2006CB601103) and the NNSFC (50772003, 20671006, 20821091, 90922004, 20971006) for financial support.

References

  1. J. Kido and Y. Okamoto, Chem. Rev., 2002, 102, 2357 CrossRef CAS.
  2. J. F. Wang, R. Y. Wang, J. Yang, Z. P. Zheng, M. D. Carducci, T. Cayou, N. Peyghambarian and G. E. Jabbour, J. Am. Chem. Soc., 2001, 123, 6179 CrossRef CAS.
  3. Z. Q. Chen, F. Ding, F. Hao, Z. Q. Bian, B. Ding, Y. Z. Zhu, F. F. Chen and C. H. Huang, Org. Electron., 2009, 10, 939 CrossRef CAS.
  4. H. Xin, F. Y. Li, M. Shi, Z. Q. A. Bian and C. H. Huang, J. Am. Chem. Soc., 2003, 125, 7166 CrossRef CAS.
  5. H. Xin, M. Shi, X. C. Gao, Y. Y. Huang, Z. L. Gong, D. B. Nie, H. Cao, Z. Q. Bian, F. Y. Li and C. H. Huang, J. Phys. Chem. B, 2004, 108, 10796 CrossRef CAS.
  6. U. Giovanella, M. Pasini, C. Freund, C. Botta, W. Porzio and S. Destri, J. Phys. Chem. C, 2009, 113, 2290 CrossRef CAS.
  7. C. R. De Silva, F. Y. Li, C. H. Huang and Z. P. Zheng, Thin Solid Films, 2008, 517, 957 CrossRef CAS.
  8. H. Xu, K. Yin and W. Huang, Chem.–Eur. J., 2007, 13, 10281 CrossRef.
  9. J. B. Yu, L. Zhou, H. J. Zhang, Y. X. Zheng, H. R. Li, R. P. Deng, Z. P. Peng and Z. F. Li, Inorg. Chem., 2005, 44, 1611 CrossRef CAS.
  10. J. Kalinowski, Opt. Mater., 2008, 30, 792 CrossRef CAS.
  11. C. Adachi, M. A. Baldo and S. R. Forrest, J. Appl. Phys., 2000, 87, 8049 CrossRef CAS.
  12. Z. Q. Bian, D. Q. Gao, K. Z. Wang, L. P. Jin and C. H. Huang, Thin Solid Films, 2004, 460, 237 CrossRef CAS.
  13. M. R. Robinson, J. C. Ostrowski, G. C. Bazan and M. D. McGehee, Adv. Mater., 2003, 15, 1547 CrossRef CAS.
  14. P. P. Sun, J. P. Duan, J. J. Lih and C. H. Cheng, Adv. Funct. Mater., 2003, 13, 683 CrossRef CAS.
  15. J. F. Fang and D. G. Ma, Appl. Phys. Lett., 2003, 83, 4041 CrossRef CAS.
  16. M. Sun, H. Xin, K. Z. Wang, Y. A. Zhang, L. P. Jin and C. H. Huang, Chem. Commun., 2003, 702 RSC.
  17. F. S. Liang, Q. G. Zhou, Y. X. Cheng, L. X. Wang, D. G. Ma, X. B. Jing and F. S. Wang, Chem. Mater., 2003, 15, 1935 CrossRef CAS.
  18. H. Xin, F. Y. Li, M. Guan, C. H. Huang, M. Sun, K. Z. Wang, Y. A. Zhang and L. P. Jin, J. Appl. Phys., 2003, 94, 4729 CrossRef CAS.
  19. M. Guan, Z. Q. Bian, F. Y. Li, H. Xin and C. H. Huang, New J. Chem., 2003, 27, 1731 RSC.
  20. Z. Liu, F. S. Wen and W. L. Li, Thin Solid Films, 2005, 478, 265 CrossRef CAS.
  21. M. D. McGehee, T. Bergstedt, C. Zhang, A. P. Saab, M. B. O’Regan, G. C. Bazan, V. I. Srdanov and A. J. Heeger, Adv. Mater., 1999, 11, 1349 CrossRef CAS.
  22. Z. R. Hong, C. S. Lee, S. T. Lee, W. L. Li and S. Y. Liu, Appl. Phys. Lett., 2003, 82, 2218 CrossRef CAS.
  23. Y. X. Zheng, J. Lin, Y. J. Liang, Y. N. Yu, Y. H. Zhou, C. Guo, S. B. Wang and H. J. Zhang, J. Alloys Compd., 2002, 336, 114 CrossRef CAS.
  24. Z. J. Wang and I. D. W. Sarnuel, J. Lumin., 2005, 111, 199 CrossRef CAS.
  25. J. B. Peng, N. Takada and N. Minami, Thin Solid Films, 2002, 405, 224 CrossRef CAS.
  26. M. Uekawa, Y. Miyamoto, H. Ikeda, K. Kaifu and T. Nakaya, Bull. Chem. Soc. Jpn., 1998, 71, 2253 CAS.
  27. M. Noto, K. Irie and M. Era, Chem. Lett., 2001, 320 CrossRef CAS.
  28. T. Sano, M. Fujita, T. Fujii, Y. Hamada, K. Shibata and K. Kuroki, Jpn. J. Appl. Phys., 1995, 34, 1883 CrossRef CAS.
  29. Y. Hamada, IEEE Trans. Electron Devices, 1997, 44, 1208 CrossRef CAS.
  30. N. Rehmann, C. Ulbricht, A. Kohnen, P. Zacharias, M. C. Gather, D. Hertel, E. Holder, K. Meerholz and U. S. Schubert, Adv. Mater., 2008, 20, 129 CrossRef CAS.
  31. X. H. Yang, D. C. Muller, D. Neher and K. Meerholz, Adv. Mater., 2006, 18, 948 CrossRef CAS.
  32. Y. T. Tao, Q. Wang, C. L. Yang, Q. Wang, Z. Q. Zhang, T. T. Zou, J. G. Qin and D. G. Ma, Angew. Chem., Int. Ed., 2008, 47, 8104 CrossRef CAS.
  33. E. J. Corey, A. L. Borror and T. Foglia, J. Org. Chem., 1965, 30, 288 CAS.
  34. J. J. Moore, J. J. Nash, P. E. Fanwick and D. R. McMillin, Inorg. Chem., 2002, 41, 6387 CrossRef CAS.
  35. C. R. De Silva, J. F. Wang, M. D. Carducci, S. A. Rajapakshe and Z. P. Zheng, Inorg. Chim. Acta, 2004, 357, 630 CrossRef CAS.
  36. C. R. De Silva, R. Y. Wang and Z. P. Zheng, Polyhedron, 2006, 25, 3449 CrossRef CAS.
  37. C. R. De Silva, J. R. Maeyer, A. Dawson and Z. P. Zheng, Polyhedron, 2007, 26, 1229 CrossRef CAS.
  38. C. Y. Hung, T. L. Wang, Z. Q. Shi and R. P. Thummel, Tetrahedron, 1994, 50, 10685 CrossRef CAS.
  39. W. F. Sager, N. Filipesc and F. A. Serafin, J. Phys. Chem., 1965, 69, 1092 CAS.
  40. S. I. Klink, L. Grave, D. N. Reinhoudt, F. C. J. M. van Veggel, M. H. V. Werts, F. A. J. Geurts and J. W. Hofstraat, J. Phys. Chem. A, 2000, 104, 5457 CrossRef CAS.
  41. S. I. Klink, G. A. Hebbink, L. Grave, P. G. B. O. Alink, F. C. J. M. van Veggel and M. H. V. Werts, J. Phys. Chem. A, 2002, 106, 3681 CrossRef CAS.
  42. G. A. Crosby, R. M. Alire and R. E. Whan, J. Chem. Phys., 1961, 34, 743 CrossRef CAS.
  43. G. A. Crosby and R. E. Whan, J. Chem. Phys., 1962, 36, 863 CrossRef CAS.
  44. X. J. Yu and Q. D. Su, J. Photochem. Photobiol., A, 2003, 155, 73 CrossRef CAS.
  45. K. Nakamaru, Bull. Chem. Soc. Jpn., 1982, 55, 2697 CAS.
  46. R. A. Campos, I. P. Kovalev, Y. Guo, N. Wakili and T. Skotheim, J. Appl. Phys., 1996, 80, 7144 CrossRef CAS.
  47. J. Kalinowski, W. Stampor, M. Cocchi, D. Virgili and V. Fattori, Appl. Phys. Lett., 2005, 86, 241106 CrossRef.
  48. T. A. Hopkins, K. Meerholz, S. Shaheen, M. L. Anderson, A. Schmidt, B. Kippelen, A. B. Padias, H. K. Hall, N. Peyghambarian and N. R. Armstrong, Chem. Mater., 1996, 8, 344 CrossRef CAS.
  49. X. Hao, S. Mei, M. Z. Xiao, Y. L. Fu, Q. B. Zu, K. Ibrahim, Q. L. Feng and H. H. Chun, Chem. Mater., 2003, 15, 3728 CrossRef CAS.
  50. M. Guan, Z. Q. Bian, Y. F. Zhou, F. Y. Li, Z. J. Li and C. H. Huang, Chem. Commun., 2003, 2708 RSC.
  51. J. F. Weiher, L. R. Melby and R. E. Benson, J. Am. Chem. Soc., 1964, 86, 4329 CrossRef.

Footnotes

Electronic supplementary information (ESI) available: Excitation spectra of complexes Eu(TTA)3BpoR and Eu(TTA)3PhoR in CH2Cl2. CCDC reference numbers 754692. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/b9nj00461k
These authors contributed equally to this work.

This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2010
Click here to see how this site uses Cookies. View our privacy policy here.